Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis - Archive ouverte HAL Access content directly
Journal Articles Acta crystallographica Section D : Structural biology [1993-...] Year : 2002

Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis

(1) , (1) , (2) , (1) , (3) , (2) , (4) , (4) , (1) , (1) , (1)
1
2
3
4

Abstract

The product of the Rv2276 gene of Mycobacterium tuberculosis is a cytochrome P450 (P450 MT2, CYP121) which has been shown to bind tightly to a range of azole-based antifungal drugs (e.g. miconazole, clotrimazole). These drugs are potent inhibitors of mycobacterial growth, suggesting that P450 MT2 (CYP121) may be a potential drug target. The enzyme has been overexpressed in Escherichia coli and crystallized by the hanging-drop method. Crystals of P450 MT2 (CYP121) belong to the hexagonal space group P6(1)22 or P6(5)22, with unit-cell parameters a = b = 78.3, c = 265.6 A. Native data have been collected to 1.6 A resolution and Hg-derivative data to 2.5 A resolution using a synchrotron-radiation source.

Dates and versions

pasteur-03144700 , version 1 (17-02-2021)

Identifiers

Cite

Christopher Mowat, David Leys, Kirsty Mclean, Stuart Rivers, Alison Richmond, et al.. Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis. Acta crystallographica Section D : Structural biology [1993-..], 2002, 58 (4), pp.704-705. ⟨10.1107/s0907444902002676⟩. ⟨pasteur-03144700⟩

Collections

PASTEUR CNRS
23 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More